Michael James Newman - Net Worth and Insider Trading
Michael James Newman Net Worth
The estimated net worth of Michael James Newman is at least $3 Million dollars as of 2024-11-13. Michael James Newman is the CSO and Director, 10% Owner of Indaptus Therapeutics Inc and owns about 2,750,842 shares of Indaptus Therapeutics Inc (INDP) stock worth over $3 Million. Details can be seen in Michael James Newman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael James Newman has not made any transactions after 2022-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael James Newman
Michael James Newman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael James Newman owns 1 companies in total, including Indaptus Therapeutics Inc (INDP) .
Click here to see the complete history of Michael James Newman’s form 4 insider trades.
Insider Ownership Summary of Michael James Newman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INDP | Indaptus Therapeutics Inc | 2022-02-01 | director & 10 percent owner & Chief Scientific Officer |
Michael James Newman Latest Holdings Summary
Michael James Newman currently owns a total of 1 stock. Michael James Newman owns 2,750,842 shares of Indaptus Therapeutics Inc (INDP) as of February 1, 2022, with a value of $3 Million.
Latest Holdings of Michael James Newman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics Inc | 2022-02-01 | 2,750,842 | 1.14 | 3,135,960 |
Holding Weightings of Michael James Newman
Michael James Newman Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael James Newman has made a total of 1 transactions in Indaptus Therapeutics Inc (INDP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Indaptus Therapeutics Inc is the sale of 20,000 shares on February 1, 2022, which brought Michael James Newman around $100,000.
Insider Trading History of Michael James Newman
- 1
Michael James Newman Trading Performance
Michael James Newman Ownership Network
Ownership Network List of Michael James Newman
Ownership Network Relation of Michael James Newman
Michael James Newman Owned Company Details
What does Indaptus Therapeutics Inc do?
Who are the key executives at Indaptus Therapeutics Inc?
Michael James Newman is the director & 10 percent owner & Chief Scientific Officer of Indaptus Therapeutics Inc. Other key executives at Indaptus Therapeutics Inc include 10 percent owner Glen R. Anderson , Chief Medical Officer Roger J. Waltzman , and Chief Medical Officer Boyan Vesselinov Litchev .
Indaptus Therapeutics Inc (INDP) Insider Trades Summary
Over the past 18 months, Michael James Newman made no insider transaction in Indaptus Therapeutics Inc (INDP). Other recent insider transactions involving Indaptus Therapeutics Inc (INDP) include a net purchase of 103,352 shares made by Glen R. Anderson ,
In summary, during the past 3 months, insiders sold 0 shares of Indaptus Therapeutics Inc (INDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Indaptus Therapeutics Inc (INDP) were sold and 103,352 shares were bought by its insiders, resulting in a net purchase of 103,352 shares.
Indaptus Therapeutics Inc (INDP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Indaptus Therapeutics Inc Insider Transactions
Michael James Newman Mailing Address
Above is the net worth, insider trading, and ownership report for Michael James Newman. You might contact Michael James Newman via mailing address: C/o Intec Parent, Inc., 12 Hartom St., Har Hotzvim, Jerusalem L3 9777512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
